Tyrosine 656 in topoisomerase II[beta] is important for the catalytic activity of the enzyme: Identification based on artifactual +80-Da modification at this site

Topoisomerase (topo) II catalyzes topological changes in DNA. Although both human isozymes, topo II[alpha] and [beta] are phosphorylated, site-specific phosphorylation of topo II[beta] is poorly characterized. Using LC-MS/MS analysis of topo II[beta], cleaved with trypsin, Arg C or cyanogen bromide...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Proteomics (Weinheim) 2011-03, Vol.11 (5), p.829
Hauptverfasser: Grozav, Adrian G, Willard, Belinda B, Kozuki, Toshiyuki, Chikamori, Kenichi, Micluta, Marius A, Petrescu, Andrei-Jose, Kinter, Michael, Ganapathi, Ram, Ganapathi, Mahrukh K
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Topoisomerase (topo) II catalyzes topological changes in DNA. Although both human isozymes, topo II[alpha] and [beta] are phosphorylated, site-specific phosphorylation of topo II[beta] is poorly characterized. Using LC-MS/MS analysis of topo II[beta], cleaved with trypsin, Arg C or cyanogen bromide (CNBr) plus trypsin, we detected four +80-Da modified sites: tyr656, ser1395, thr1426 and ser1545. Phosphorylation at ser1395, thr1426 and ser1545 was established based on neutral loss of H3PO4 (-98Da) in the CID spectra and on differences in 2-D-phosphopeptide maps of 32P-labeled wild-type (WT) and S1395A or T1426A/S1545A mutant topo II[beta]. However, phosphorylation at tyr656 could not be verified by 2-D-phosphopeptide mapping of 32P-labeled WT and Y656F mutant protein or by Western blotting with phosphotyrosine-specific antibodies. Since the +80-Da modification on tyr656 was observed exclusively during cleavage with CNBr and trypsin, this modification likely represented bromination, which occurred during CNBr cleavage. Re-evaluation of the CID spectra identified +78/+80-Da fragment ions in CID spectra of two peptides containing tyr656 and tyr711, confirming bromination. Interestingly, mutation of only tyr656, but not ser1395, thr1326 or ser1545, decreased topo II[beta] activity, suggesting a functional role for tyr656. These results, while identifying an important tyrosine in topo II[beta], underscore the importance of careful interpretation of modifications having the same nominal mass. [PUBLICATION ABSTRACT]
ISSN:1615-9853
1615-9861
DOI:10.1002/pmic.201000194